MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-UP-63-0007723
Apmida Pharmaceuticals Private Limited
Apmida Pharmaceuticals Private Limited - pharma in Rampur, Uttar Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹14.28 Cr
▲ 669% YoY
Net profit · FY 2025
₹3.56 Lakh
Net margin 0.2%
EBITDA · FY 2025
₹4.37 Cr
EBITDA margin 30.6%
Authorised capital
₹7.5 Cr
Registered with MCA
Paid-up capital
₹6 Cr
Issued & subscribed
Open charges
₹26.33 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
11
Provident fund records
About Apmida Pharmaceuticals Private Limited
Data last updated:
Apmida Pharmaceuticals Private Limited is a private limited company based in Rampur, Uttar Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 27 May 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2022PTC164942. Its GSTIN is 09AAXCA0724B1ZS (Uttar Pradesh).
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹6 Cr. It is led by directors including Mohit Jain and Dheeraj Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Near District Judge Kothi Moradabad Road, Rampur, Uttar Pradesh, India – 244901.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.28 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.56 Lakh (net margin 0.2%) and EBITDA of ₹4.37 Cr (EBITDA margin 30.6%).
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹26.33 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Apmida Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-UP-63-0007723). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290UP2022PTC164942
Registration Number 164942
Incorporation Date 27 May 2022
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-UP-63-0007723
Recognitions & Rankings of Apmida Pharmaceuticals
Contact details
Apmida Pharmaceuticals Private Limited's registered office is in Rampur, Uttar Pradesh.
- Registered AddressNear District Judge Kothi Moradabad Road, Rampur, Uttar Pradesh, India – 244901
- IndustryPharma, API Manufacturers
Comprehensive company report
Apmida Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Apmida Pharmaceuticals Private Limited
FY 2025 filings availableApmida Pharmaceuticals Private Limited reported revenue of ₹14.28 Cr (up 669% YoY) for FY 2025.
Revenue · FY 2025
₹14.28 Cr ▲ 669%
Net profit · FY 2025
₹3.56 Lakh margin 0.2%
EBITDA · FY 2025
₹4.37 Cr margin 30.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 669%
EBITDA CAGR growth
1 year
▲ 771%
Revenue rose 669% in the latest year. EBITDA rose 771% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4.37 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3.56 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 30.6% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Apmida Pharmaceuticals Private Limited, buy the company report.
Board of directors of Apmida Pharmaceuticals Private Limited
Apmida Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohit Jain | Director | 27 May 2022 | 4 Years 5 Months | Current |
| Dheeraj Jain | Director | 27 May 2022 | 4 Years 5 Months | Current |
| Ashu Jain | Director | 27 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Apmida Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iza Pharmaceuticals Private Limited | ₹14.44 Cr (FY 2025) | 21.0% | Kozhikode, Kerala, India | |||
| Bhavna Laboratories Pvt Ltd | ₹14.42 Cr (FY 2025) | -1.0% | Thane, Maharashtra, India | |||
| Reign Pharma Private Limited | ₹14.41 Cr (FY 2025) | 668.0% | Junagadh, Gujarat, India | |||
| Reehel Pharmaceuticals Private Limited | ₹14.32 Cr (FY 2023) | -1.0% | Ahmedabad, Gujarat, India | |||
| Guru Ashish Pharma Chem Private Limited | ₹14.28 Cr (FY 2025) | 394.0% | Ankleshwar, Gujarat, India | |||
| Apmida Pharmaceuticals Private Limitedthis company | ₹14.28 Cr (FY 2025) | ₹3.56 Lakh | 0.2% | 669.0% | Rampur, Uttar Pradesh, India | |
| Park N Chem Pharmaceuticals Private Limited | ₹14.16 Cr (FY 2025) | -3.0% | Amritsar, Punjab, India | |||
| Eskay Engichem Private Limited | ₹14.11 Cr (FY 2025) | 15.0% | Pune, Maharashtra, India | |||
| Fling Pharmaceuticals Private Limited | ₹14.1 Cr (FY 2024) | -21.0% | Thrissur, Kerala, India | |||
| Okinawa Pharmaceuticals Private Limited | ₹14.1 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Agonist Pharmaceuticals Private Limited | ₹13.99 Cr (FY 2022) | 50.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Apmida Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹26.33 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Dec 2022 | 100654754 | Others | ₹26.33 Cr | Open |
To see the full charge records of Apmida Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Apmida Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Apmida Pharmaceuticals. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Moradabad, Uttar Pradesh | Civil suit | Filed by the company against M/S D.K Scientific Equipments | Pending |
| District court, Moradabad, Uttar Pradesh | Civil suit | Filed by the company against M/S D.K Scientific Equipments | Disposed |
To see the full case history of Apmida Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apmida Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Apmida Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAXCA0724B1ZS | Uttar Pradesh | Active | 13 Jun 2022 |
To see the full GST registrations and return filing status of Apmida Pharmaceuticals Private Limited, buy the company report.
Recent activity
Apmida Pharmaceuticals Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Ashu Jain was appointed as Director on 27 May 2022.
AGM
Apmida Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Apmida Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Others of Rs. 26.33 Cr registered on 06 Dec 2022 with Charge ID 100654754 was modified on 14 Aug 2024.
Charges
A charge with Others amounted to Rs. 26.33 Cr with Charge ID 100654754 was registered on 06 Dec 2022.
Appointed
Ashu Jain was appointed as Director.
Appointed
Dheeraj Jain was appointed as Director.
Appointed
Mohit Jain was appointed as Director.
Incorporation
27 May 2022
Apmida Pharmaceuticals Private Limited was registered on 27 May 2022 with Roc Uttar Pradesh I & aged 4 years 5 months as per MCA records.
Frequently asked questions
Apmida Pharmaceuticals is an active private limited company based in Rampur, Uttar Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 27 May 2022 (4+ years old) and is registered under CIN U24290UP2022PTC164942.
Apmida Pharmaceuticals has 3 current directors:
- Mohit Jain - Director
- Dheeraj Jain - Director
- Ashu Jain - Director
The latest financial statements of Apmida Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Apmida Pharmaceuticals is 09AAXCA0724B1ZS, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Apmida Pharmaceuticals is U24290UP2022PTC164942. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apmida Pharmaceuticals has 2 court cases on record: 2 filed by the company. 1 is pending.
Apmida Pharmaceuticals was incorporated on 27 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Apmida Pharmaceuticals by revenue are Iza Pharmaceuticals Private Limited, Bhavna Laboratories Pvt Ltd, Reign Pharma Private Limited, Reehel Pharmaceuticals Private Limited, Guru Ashish Pharma Chem Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals).
Ashu Jain was appointed as Director on 27 May 2022. Dheeraj Jain was appointed as Director on 27 May 2022. Mohit Jain was appointed as Director on 27 May 2022.
Yes, Apmida Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-UP-63-0007723).
The registered office of Apmida Pharmaceuticals is at Near District Judge Kothi Moradabad Road, Rampur, Uttar Pradesh, India – 244901.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages